Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 5/2009

01-05-2009 | Correspondence

Interstitial lung disease associated with oxaliplatin: description of two cases

Authors: Carolina Pena Álvarez, Hae Jin Suh Oh, Andrea Sáenz de Miera Rodríguez, Francisco Ramón García Arroyo, Marta Covela Rúa, Laura Salgado Boquete, Pedro Miguel López Clemente, Manuel Constenla Figueiras

Published in: Clinical and Translational Oncology | Issue 5/2009

Login to get access
Metadata
Title
Interstitial lung disease associated with oxaliplatin: description of two cases
Authors
Carolina Pena Álvarez
Hae Jin Suh Oh
Andrea Sáenz de Miera Rodríguez
Francisco Ramón García Arroyo
Marta Covela Rúa
Laura Salgado Boquete
Pedro Miguel López Clemente
Manuel Constenla Figueiras
Publication date
01-05-2009
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 5/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-009-0364-4

Other articles of this Issue 5/2009

Clinical and Translational Oncology 5/2009 Go to the issue

Brief Research Articles

Bronchogenic carcinoma in patients under 50 years old

Educational Series

SEOM guidelines for the management of non-small-cell lung cancer (NSCLC)

Educational Series

Role of stereotactic body radiotherapy in the management of primary hepatocellular carcinoma. Rationale, technique and results

Special Article

Consensus on the treatment of pancreatic cancer in Spain

Educational Series

Resistance mechanisms of tumour cells to EGFR inhibitors

Brief Research Articles

Diagnosis of paediatric anaplastic large-cell lymphoma: a historical perspective from a single institution
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits